What Kind of Liver Disease Can Be Treated with Stem Cell Treatment?

Stem cell treatment is a new area of research for treating liver diseases. Stem cell treatments provide a potential treatment approach for regenerating liver tissue and treating diseases that can lead to liver failure. The adult liver has an exceptional ability to regenerate itself, but in some chronic diseases or cases of severe liver damage, the liver’s ability to regenerate may not overcome the disease process. Stem cell treatments intend to utilize the regenerative ability of stem cells to regenerate liver tissue, repair liver function, and possibly avoid the need for transplantation.

Liver Diseases That Can Be Treated Using Stem Cell Therapy

Although research and clinical application of stem cell therapies to treat liver disease still have some way to go, there is considerable hope for treating various forms of liver disease. Here is a description of the types of liver disease that can be treated with stem cell therapies:

Chronic Liver Disease (CLD) 

Chronic liver diseases, especially those that generate cirrhosis of the liver, have potential utility for stem cell therapy focused on repairing damaged liver cells and/or reversing fibrosis. The most common chronic diseases that may be treated with stem cells are:

Cirrhosis:

• Cirrhosis is a condition where the liver has severe scarring that results from chronic liver injury (chronic hepatitis, alcohol use, non-alcoholic fatty liver disease [NAFLD]). Cirrhosis results in liver failure over time.
• Stem cells can potentially be used to treat cirrhosis through enhancement of liver regeneration, elimination of inflammation, and improvement of damaged liver cell repair.

NASH (Non-Alcoholic Steatohepatitis):

• NASH is a serious form of NAFLD characterized by liver inflammation and injury associated with liver fat accumulation, which can eventually lead to cirrhosis. Stem cell therapy is being examined for its potential to reduce liver fat accumulation, restore liver function, and reduce inflammation.

Hepatitis-related Liver Disease:

• Liver cirrhosis and liver cancer (hepatocellular carcinoma, HCC) are typically caused by chronic viral infections with hepatitis B or hepatitis C. Stem cell treatment strategies are being investigated to treat hepatic fibrosis resulting from chronic hepatitis B or C infections.

Alcoholic Liver Disease:

• Chronic alcohol consumption can lead to liver damage (e.g., fatty liver, hepatitis, and cirrhosis). Stem cell therapy may be used to aid in the regeneration of liver cells and/or liver fibrosis as a result of alcohol-induced liver pathology.

Hypotensive Fibrosis and Fibrotic Liver Illness

• Hypotensive fibrosis pertains to the development of scar tissue in the liver, usually as a result of chronic liver damage (from viruses, alcohol, or fatty liver disease). If hypotensive fibrosis evolves to cirrhosis, the functionality of the liver may be significantly impaired.
• Mesenchymal stem cells (MSCs) and the analog of hepatocyte progenitor cells are being studied for their role in the infiltration of hypotensive fluid with the repair of injurious tissue and mending the scar tissue.

Hypotensive Failure 

• Acute hypotensive failure or chronic hypotensive failure can develop after sudden, severe damage to the liver; this injury is typically caused by toxins (examples include drug overdoses or alcohol), viral infections, or metabolic disorders (such as Wilson’s disease). In this scenario, the liver does not regenerate adequately, and sometimes the remedy is liver transplantation.
• Consequently, stem cells may be beneficial in carrying out this role by promoting liver repair and/or regeneration of liver function. For example, there is evidence that this can possibly be achieved through the reimplantation or infusion of hepatocytes (which are liver cells) or liver progenitor cells derived from stem cells to restore liver function in the context of liver failure.

Genetic Hepatic Disorders

A genetic hepatic disorder or disease is caused by genetic mutations that result in impairment of hepatic function and metabolism. Stem cell therapy in the future may offer treatment options to either correct or manage these disorders.

Wilson’s Disease:

• Wilson’s disease is an autosomal recessive genetic disorder that involves an accumulation of copper in the liver leading to liver damage, cirrhosis, and neurological symptoms. Stem cell therapy may provide a treatment option for Wilson’s disease in the future by regenerating liver cells and correcting the abnormal metabolism of copper.

Alpha-1 Antitrypsin Deficiency:

• This inherited condition can produce liver disease and emphysema as a result of the deficiency of the protein alpha-1 antitrypsin. Replacement of defective liver tissue with stem cell therapy could lead to regeneration of the liver and correction of alpha-1 antitrypsin production. 

Hemochromatosis:

• Hemochromatosis is an inherited condition where there is too much iron in the body, including the liver, that can cause liver disease. Stem cell therapy may help regenerate liver tissue and correct iron metabolism.

Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease (NAFLD):

• NAFLD is a condition that involves an accumulation of fat in the liver in the absence of any alcohol. In some cases, NAFLD progresses to NASH, which is characterized by inflammation and scarring. Stem cell approaches are currently being investigated for their possibilities of reducing the accumulation of fat in the liver, supporting cell regeneration, and reducing inflammation.

Alcoholic Fatty Liver Disease:

• When excessive alcohol ingestion leads to fatty liver, stem cells may have the potential to repair the liver tissue, resolve fat accumulation, and prevent the development of cirrhosis.

Liver Cancer (Hepatocellular Carcinoma) 

• Hepatocellular carcinoma (HCC) is the most common primary liver cancer, typically arising in the setting of chronic liver disease or cirrhosis.
• Stem cell therapy is being investigated not only to treat the problems of liver cirrhosis and liver failure but also as an adjunctive therapy to treat liver cancer. Stem cells may work to regenerate liver tissue following liver cancer therapy (surgery or liver transplant) and to enhance the immune system’s targeting of cancer cells.

Types of Stem Cells Being Used to Treat Liver Disease

There are several types of stem cells being tested for liver disease:

1. Mesenchymal Stem Cells (MSCs):

• These stem cells can be obtained from various sources, including the bone marrow, adipose tissue, or umbilical cord tissue. MSCs have immunomodulatory effects and can promote tissue repair and regeneration by secreting bioactive molecules that promote the regeneration of liver cells and reduce inflammation.

2. Hematopoietic Stem Cells (HSCs):

• HSCs are obtained from the bone marrow, and they can be differentiated into different cell types, including liver cells. Research is ongoing to evaluate their use in the treatment of liver disease, with particular emphasis on mediating liver regeneration.

3. Hepatocyte Progenitor Cells:

• These stem cells can differentiate into mature hepatocytes (liver cells). They are especially useful in conditions where regeneration in the liver is declined, such as liver failure or cirrhosis.

4. Induced Pluripotent Stem Cells (iPSCs):

• iPSCs are adult cells (e.g., skin cells) that have been genetically reprogrammed to return to a pluripotent state, enabling them to develop into any cell type, including hepatocytes. iPSCs offer potential use for liver disease treatment, especially if a patient’s own cells are used, to prevent immune rejection.

5. Liver-Derived Stem Cells:

• Stem cells can also be derived from the liver itself, for example, the liver’s own progenitor cells, which may be another source of liver cells for regenerative therapy.

FAQs

1. Which liver diseases can be treated using stem cell therapies?

Stem cell therapy shows promise for chronic liver diseases, cirrhosis, liver damage from hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NAFLD/NASH), genetic disorders, and possibly even liver cancers.

2. How do stem cells work to help the treatment of liver disease?

Stem cells aid in regenerating liver tissue, ameliorating inflammation, and repairing damaged/deficient scar cells, and they may help delay or eliminate the need for liver transplantation.

3. Do stem cell therapies provide a cure for genetic liver disorders?

There is data to suggest that stem cell therapy may assist in managing diseases such as Wilson’s disease, Alpha-1 Antitrypsin deficiency, or Hemochromatosis through end-stage liver cell regeneration and metabolism correction. 

4. What types of stem cells are being used in liver treatments?

Types of stem cells being used in liver repair, restoration, and regeneration include mesenchymal stem cells, hematopoietic stem cells, hepatocyte progenitor cells, induced pluripotent stem cells, and liver-derived progenitor cells.